Bridging barriers: advances and challenges in modeling biological barriers and measuring barrier integrity in organ-on-chip systems

Alisa Ugodnikov, Henrik Persson and Craig A. Simmons

Lab Chip, 2024, 24, 3199
DOI: 10.1039/D3LC01027A

Integrating emerging science to improve estimates of risk to wildlife from chemical exposure: What are the challenges?

Nico W. van den Brink, John E. Elliott, Beth Power, Clare Kilgour and Mark S. Johnson

Integrated Environmental Assessment and Management, 2024, 20, 645
DOI: 10.1002/ieam.4897

Current status of MPS studies in domestic and overseas—introduction of cardiac MPS—

Daiju Yamazaki

Folia Pharmacol. Jpn., 2025, 160, 87
DOI: 10.1254/fpj.24070

Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives

Sonia Youhanna, Aurino M. Kemas, Lena Preiss, Yitian Zhou, Joanne X. Shen, Selgin D. Cakal, Francesco S. Paqualini, Sravan K. Goparaju, Reza Zandi Shafagh, Johan Ulrik Lind, Carl M. Sellgren and Volker M. Lauschke

Pharmacological Reviews, 2022, 74, 141
DOI: 10.1124/pharmrev.120.000238

Mouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants

F. Jardi, C. Kelly, C. Teague, H. Fowler-Williams, D. C. Sevin, D. Rodrigues, H. Jo, S. Ferreira, B. Herpers, M. Van Heerden, T. de Kok, C. Pin, A. Lynch, C. A. Duckworth, S. De Jonghe, L. Lammens and D. M. Pritchard

Arch Toxicol, 2023, 97, 235
DOI: 10.1007/s00204-022-03374-3

The differentiation state of small intestinal organoid models influences prediction of drug-induced toxicity

Jessica A. Klein, Julia D. Heidmann, Tomomi Kiyota, Aaron Fullerton, Kimberly A. Homan and Julia Y. Co

Front. Cell Dev. Biol., 2025, 13
DOI: 10.3389/fcell.2025.1508820

Culturing the unculturables: strategies, challenges, and opportunities for gut microbiome study

Asha Yadav, Shruti Ahlawat and Krishna K Sharma

Journal of Applied Microbiology, 2023, 134
DOI: 10.1093/jambio/lxad280

The Use of MPS in Three Rs and Regulatory Applications: Perspectives From Developers on Stakeholder Responsibilities

Megan R. LaFollette, Szczepan W. Baran, J. Lowry Curley, Anne M. Dickinson, Trivia Frazier, Nina Hobi, Ming-I Huang, Victoria Hutter, Benoît G.C. Maisonneuve, Graham A. Marsh, Rhamiya Mahendran, Iris Müller, Xiaohua Qian, Dharaminder Singh, William R. Thelin, Jelena Vukasinovic, Pelin L. Candarlioglu and Clive S. Roper

Altern Lab Anim, 2025, 53, 26
DOI: 10.1177/02611929241310566

Organs-on-chips: into the next decade

Lucie A. Low, Christine Mummery, Brian R. Berridge, Christopher P. Austin and Danilo A. Tagle

Nat Rev Drug Discov, 2021, 20, 345
DOI: 10.1038/s41573-020-0079-3

A versatile, compartmentalised gut-on-a-chip system for pharmacological and toxicological analyses

Pim de Haan, Milou J. C. Santbergen, Meike van der Zande, Hans Bouwmeester, Michel W. F. Nielen and Elisabeth Verpoorte

Sci Rep, 2021, 11
DOI: 10.1038/s41598-021-84187-9

Quantitative systems modeling approaches towards model-informed drug development: Perspective through case studies

Meghna Verma, Louis Gall, Jacopo Biasetti, Giovanni Y. Di Veroli, Cesar Pichardo-Almarza, Megan A. Gibbs and Holly Kimko

Front. Syst. Biol., 2023, 2
DOI: 10.3389/fsysb.2022.1063308

The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development

Zhengying Zhou, Jinwei Zhu, Muhan Jiang, Lan Sang, Kun Hao and Hua He

Pharmaceutics, 2021, 13, 704
DOI: 10.3390/pharmaceutics13050704

Morphological alterations in C57BL/6 mouse intestinal organoids as a tool for predicting chemical-induced toxicity

Ziwei Wang, Shen Chen, Yaqin Pang, Lizhu Ye, Qi Zhang, Xinhang Jiang, Rui Zhang, Miao Li, Zhanyu Guo, Yue Jiang, Daochuan Li, Xiumei Xing, Liping Chen, Michael Aschner and Wen Chen

Arch Toxicol, 2023, 97, 1133
DOI: 10.1007/s00204-023-03451-1

Retinal organoids and microfluidic chip-based approaches to explore the retinitis pigmentosa with USH2A mutations

Ting Su, Liying Liang, Lan Zhang, Jianing Wang, Luyin Chen, Caiying Su, Jixing Cao, Quan Yu, Shuai Deng, Hon Fai Chan, Shibo Tang, Yonglong Guo and Jiansu Chen

Front. Bioeng. Biotechnol., 2022, 10
DOI: 10.3389/fbioe.2022.939774

Toward Inclusivity in Preclinical Drug Development: A Proposition to Start with Intestinal Organoids

Julia Y. Co, Jessica A. Klein, Serah Kang and Kimberly A. Homan

Advanced Biology, 2023, 7
DOI: 10.1002/adbi.202200333

Editorial overview of the special issue on application of tissue chips in toxicology

Ivan Rusyn and Adrian Roth

Toxicology, 2021, 450, 152687
DOI: 10.1016/j.tox.2021.152687

A Synthetic Hydrogel, VitroGel® ORGANOID-3, Improves Immune Cell-Epithelial Interactions in a Tissue Chip Co-Culture Model of Human Gastric Organoids and Dendritic Cells

Michelle D. Cherne, Barkan Sidar, T. Andrew Sebrell, Humberto S. Sanchez, Kody Heaton, Francis J. Kassama, Mandi M. Roe, Andrew B. Gentry, Connie B. Chang, Seth T. Walk, Mark Jutila, James N. Wilking and Diane Bimczok

Front. Pharmacol., 2021, 12
DOI: 10.3389/fphar.2021.707891

Global expansion of microphysiological systems (MPS) and Japan's initiatives: Innovation in pharmaceutical development and path to regulatory acceptance

Daiju Yamazaki and Seiichi Ishida

Drug Metabolism and Pharmacokinetics, 2025, 60, 101047
DOI: 10.1016/j.dmpk.2024.101047

Human small intestinal organotypic culture model for drug permeation, inflammation, and toxicity assays

Jan Markus, Tim Landry, Zachary Stevens, Hailey Scott, Pierre Llanos, Michelle Debatis, Alexander Armento, Mitchell Klausner and Seyoum Ayehunie

In Vitro Cell.Dev.Biol.-Animal, 2021, 57, 160
DOI: 10.1007/s11626-020-00526-6

WITHDRAWN: Mera: A scalable high throughput automated micro-physiological system

Finola E. Cliffe, Conor Madden, Patrick Costello, Shane Devitt, Sumir Ramesh Mukkunda, Bhairavi Bengaluru Keshava, Howard O. Fearnhead, Aiste Vitkauskaite, Mahshid H. Dehkordi, Walter Chingwaru, Milosz Przyjalgowski, Natalia Rebrova and Mark Lyons

SLAS Discovery, 2023, 100134
DOI: 10.1016/j.slasd.2023.12.006

Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety

Christopher E. Goldring, Giusy Russomanno, Carmen Pin, Panuwat Trairatphisan, Kylie A. Beattie, Ciarán P. Fisher, Janet Piñero, Richard J. Brennan, Diana Clausznitzer, Ian M. Copple, Theo M. de Kok, Carrie A. Duckworth, Laura I. Furlong, Barbara Füzi, Attila Gabor, Louis Gall, Jan Hengstler, Henning Hermjakob, Fiona Hunter, Danyel Jennen, Mikko Koskinen, Steven J. Kunnen, Lieve Lammens, Sebastian Lobentanzer, Marcel Mohr, Elisa Passini, D. Mark Pritchard, Rahuman S. Malik-Sheriff, Blanca Rodríguez, Eric I. Rossman, Julio Saez-Rodríguez, Friedemann Schmidt, Rowena Sison-Young, Inari Soininen, Sean Turner, Bob van de Water, Johan G. C. van Hasselt, Filippo Venezia, Jeffrey A. Willy, Derek J. Leishman, James L. Stevens and Loic Laplanche

Nat Rev Drug Discov, 2026, 25, 138
DOI: 10.1038/s41573-025-01308-z

Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development

Lindsay Tomlinson, Diane Ramsden, Sofia Batista Leite, Sonja Beken, Jessica A. Bonzo, Paul Brown, Pelin L. Candarlioglu, Tom S. Chan, Eugene Chen, Colin K. Choi, Rhiannon David, Nathalie Delrue, Patrick J. Devine, Kevin Ford, Martha Iveth Garcia, James R. Gosset, Philip Hewitt, Kimberly Homan, Onyi Irrechukwu, Anna K. Kopec, Jennifer L. Liras, Sandhya Mandlekar, Arek Raczynski, Nakissa Sadrieh, Melanie Z. Sakatis, Jeffrey Siegel, Kyung Sung, Ilona Sunyovszki, Terry R. Van Vleet, Jason E. Ekert and Rhiannon N. Hardwick

Advanced Biology, 2024, 8
DOI: 10.1002/adbi.202300131

High-throughput assay for predicting diarrhea risk using a 2D human intestinal stem cell-derived model

Colleen M. Pike, James A. Levi, Lauren A. Boone, Swetha Peddibhotla, Jacob Johnson, Bailey Zwarycz, Maureen K. Bunger, William Thelin and Elizabeth M. Boazak

Toxicology in Vitro, 2025, 106, 106040
DOI: 10.1016/j.tiv.2025.106040

Harnessing human colonoid-derived monolayers as an in vitro platform for investigating accumulation, toxicity, and pharmacodynamics of small molecules

Pedro G.M. Canhão, Anny Smeuninx, Suzy Geerinckx, Raymond Evers, Jan Snoeys, Patrick Augustijns and Stephanie Kourula

Toxicology in Vitro, 2026, 106221
DOI: 10.1016/j.tiv.2026.106221

Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples

Carmen Pin, Teresa Collins, Megan Gibbs and Holly Kimko

AAPS J, 2021, 23
DOI: 10.1208/s12248-021-00580-2

Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy

Eimear T. O’Mahony, Christopher M. Arian, Kayenat S. Aryeh, Kai Wang, Kenneth E. Thummel and Edward J. Kelly

Pharmacology & Therapeutics, 2025, 273, 108879
DOI: 10.1016/j.pharmthera.2025.108879

In vitro generation of self-renewing human intestinal epithelia over planar and shaped collagen hydrogels

Samuel S. Hinman, Yuli Wang, Raehyun Kim and Nancy L. Allbritton

Nat Protoc, 2021, 16, 352
DOI: 10.1038/s41596-020-00419-8

Disruption of serotonin homeostasis in intestinal organoids provides insights into drug-induced gastrointestinal toxicity

Georgia M. Rouseti, Audrey Fischer, Nicole Rathfelder, Karen Grimes, Annick Waldt, Rachel Cuttat, Sven Schuierer, Sophia Wild, Magali Jivkov, Valerie Dubost, Heiko S. Schadt, Alex Odermatt, Axel Vicart and Francesca Moretti

Toxicology, 2025, 511, 154028
DOI: 10.1016/j.tox.2024.154028

Microphysiological systems: What it takes for community adoption

Passley Hargrove-Grimes, Lucie A Low and Danilo A Tagle

Exp Biol Med (Maywood), 2021, 246, 1435
DOI: 10.1177/15353702211008872

Evaluation of the risk of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors with cultured intestinal stem cells originated from crypts in humans and monkeys

Yoshiki Hashimoto, Kazuya Maeda, Osamu Shimomura, Yoshihiro Miyazaki, Shinji Hashimoto, Akiko Moriyama, Tatsuya Oda and Hiroyuki Kusuhara

Toxicology in Vitro, 2023, 93, 105691
DOI: 10.1016/j.tiv.2023.105691

iPSC-derived and Patient-Derived Organoids: Applications and challenges in scalability and reproducibility as pre-clinical models

Elisa Heinzelmann, Francesco Piraino, Mariana Costa, Aline Roch, Maxim Norkin, Virginie Garnier, Krisztian Homicsko and Nathalie Brandenberg

Current Research in Toxicology, 2024, 7, 100197
DOI: 10.1016/j.crtox.2024.100197

The application of organoids in treatment decision-making for digestive system cancers: progress and challenges

Yufei Wang, Limin Zhang, Louis Zizhao Wang, Yang Cao, Lulu Huang, Gautam Sethi, Xiaoguang Chen, Lingzhi Wang and Boon-Cher Goh

Mol Cancer, 2025, 24
DOI: 10.1186/s12943-025-02429-0

Acute radiation syndrome drug discovery using organ-on-chip platforms

Vijay K. Singh and Thomas M. Seed

Expert Opinion on Drug Discovery, 2022, 17, 865
DOI: 10.1080/17460441.2022.2099833

Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges

Jingwei Li, Jianhua Liu, Wuzheng Xia, Hongwei Yang, Weihong Sha and Hao Chen

Technol Cancer Res Treat, 2024, 23
DOI: 10.1177/15330338231221856

Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications

Samantha Faber, Tejas Lahoti, Ewan Taylor, Lauren Lewis, Jessica Sapiro, Vicencia Toledo Sales, Yvonne Dragan and Brandon Jeffy

Cells, 2022, 11, 1708
DOI: 10.3390/cells11101708

Human Small Intestinal Tissue Models to Assess Barrier Permeability: Comparative Analysis of Caco-2 Cells, Jejunal and Duodenal Enteroid-Derived Cells, and EpiIntestinalTM Tissues in Membrane-Based Cultures with and Without Flow

Haley L. Moyer, Leoncio Vergara, Clifford Stephan, Courtney Sakolish, Hsing-Chieh Lin, Weihsueh A. Chiu, Remi Villenave, Philip Hewitt, Stephen S. Ferguson and Ivan Rusyn

Bioengineering, 2025, 12, 809
DOI: 10.3390/bioengineering12080809

Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities

Tengku Ibrahim Maulana, Nienke R. Wevers, Theodora Kristoforus, Morgan Chandler, Henriette L. Lanz, Jos Joore, Paul Vulto, Remi Villenave, Stefan Kustermann, Peter Loskill and Kristin M. Bircsak

Annual Review of Pharmacology and Toxicology, 2025, 65, 47
DOI: 10.1146/annurev-pharmtox-061724-080621

A call to action: Advancing new approach methodologies (NAMs) in regulatory toxicology through a unified framework for validation and acceptance

G. Ouedraogo, N. Alépée, B. Tan and C.S. Roper

Regulatory Toxicology and Pharmacology, 2025, 162, 105904
DOI: 10.1016/j.yrtph.2025.105904

Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment

Hitoshi Naraoka

Folia Pharmacol. Jpn., 2023, 158, 187
DOI: 10.1254/fpj.22116

Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules

Stephanie Kourula, Merel Derksen, Ferran Jardi, Sophie Jonkers, Marjolein van Heerden, Peter Verboven, Veronique Theuns, Stijn Van Asten, Tinne Huybrechts, Annett Kunze, Ewa Frazer-Mendelewska, Ka Wai Lai, René Overmeer, Jamie Lee Roos, Robert G.J. Vries, Sylvia F. Boj, Mario Monshouwer, Farzin Pourfarzad and Jan Snoeys

European Journal of Pharmaceutical Sciences, 2023, 188, 106481
DOI: 10.1016/j.ejps.2023.106481

Towards in vitro models for reducing or replacing the use of animals in drug testing

David M. Stresser, Anna K. Kopec, Philip Hewitt, Rhiannon N. Hardwick, Terry R. Van Vleet, Prathap Kumar S. Mahalingaiah, Denice O’Connell, Gary J. Jenkins, Rhiannon David, Jessica Graham, Donna Lee, Jason Ekert, Aaron Fullerton, Remi Villenave, Piyush Bajaj, James R. Gosset, Sherry L. Ralston, Manti Guha, Alejandro Amador-Arjona, Kainat Khan, Saket Agarwal, Catrin Hasselgren, Xiaoting Wang, Khary Adams, Gaurav Kaushik, Arkadiusz Raczynski and Kimberly A. Homan

Nat. Biomed. Eng, 2023, 8, 930
DOI: 10.1038/s41551-023-01154-7

Development of the serotonin release assay with enterochromaffin cell-rich human intestinal organoids for the risk evaluation of drug-induced emesis

Yoshiki Hashimoto, Kazuya Maeda, Osamu Shimomura, Yoshihiro Miyazaki, Shinji Hashimoto, Tatsuya Oda and Hiroyuki Kusuhara

Toxicological Sciences, 2025, 206, 299
DOI: 10.1093/toxsci/kfae158

Potential applications of microfluidics based blood brain barrier (BBB)-on-chips for in vitro drug development

Xiaobo Wang, Ya Hou, Xiaopeng Ai, Jiayi Sun, Binjie Xu, Xianli Meng, Yi Zhang and Sanyin Zhang

Biomedicine & Pharmacotherapy, 2020, 132, 110822
DOI: 10.1016/j.biopha.2020.110822

Leveraging Organ‐on‐Chip Models to Investigate Host–Microbiota Dynamics and Targeted Therapies for Inflammatory Bowel Disease

Tim Kaden, Raquel Alonso‐Román, Johannes Stallhofer, Mark S. Gresnigt, Bernhard Hube and Alexander S. Mosig

Adv Healthcare Materials, 2025, 14
DOI: 10.1002/adhm.202402756

The evolving role of investigative toxicology in the pharmaceutical industry

Francois Pognan, Mario Beilmann, Harrie C. M. Boonen, Andreas Czich, Gordon Dear, Philip Hewitt, Tomas Mow, Teija Oinonen, Adrian Roth, Thomas Steger-Hartmann, Jean-Pierre Valentin, Freddy Van Goethem, Richard J. Weaver and Peter Newham

Nat Rev Drug Discov, 2023, 22, 317
DOI: 10.1038/s41573-022-00633-x

Bioengineered human gut-on-a-chip for advancing non-clinical pharmaco-toxicology

Yong Cheol Shin, Nam Than, Soo Jin Park and Hyun Jung Kim

Expert Opinion on Drug Metabolism & Toxicology, 2024, 20, 593
DOI: 10.1080/17425255.2024.2365254

Fabrication of facile assembly shrinkable double-responsive nanoparticles: Investigation of anticancer activity in lung cancer cells and apoptosis induction

Ping Huang, Zhe Chen, Tingjian Li, Kangtai Ying, Lingjian Xie and Bingqing Ruan

Process Biochemistry, 2024, 137, 175
DOI: 10.1016/j.procbio.2023.12.023

Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells

Elena Naumovska, Germaine Aalderink, Christian Wong Valencia, Kinga Kosim, Arnaud Nicolas, Stephen Brown, Paul Vulto, Kai S. Erdmann and Dorota Kurek

IJMS, 2020, 21, 4964
DOI: 10.3390/ijms21144964

Comparative analysis of Caco-2 cells and human jejunal and duodenal enteroid-derived cells in gel- and membrane-based barrier models of intestinal permeability

Haley L Moyer, Leoncio Vergara, Clifford Stephan, Courtney Sakolish, Lucie C Ford, Han-Hsuan D Tsai, Hsing-Chieh Lin, Weihsueh A Chiu, Remi Villenave, Philip Hewitt, Stephen S Ferguson and Ivan Rusyn

Toxicological Sciences, 2025, 204, 181
DOI: 10.1093/toxsci/kfaf011

Mera: A scalable high throughput automated micro-physiological system

Finola E. Cliffe, Conor Madden, Patrick Costello, Shane Devitt, Sumir Ramesh Mukkunda, Bhairavi Bengaluru Keshava, Howard O. Fearnhead, Aiste Vitkauskaite, Mahshid H. Dehkordi, Walter Chingwaru, Milosz Przyjalgowski, Natalia Rebrova and Mark Lyons

SLAS Technology, 2023, 28, 230
DOI: 10.1016/j.slast.2023.01.004

Complex in vitro models positioned for impact to drug testing in pharma: a review

Serah Kang, Eugene C Chen, Helen Cifuentes, Julia Y Co, Gabrielle Cole, Jessica Graham, Rebecca Hsia, Tomomi Kiyota, Jessica A Klein, Katharina T Kroll, Lenitza M Nieves Lopez, Leah M Norona, Heshan Peiris, Ratnakar Potla, Monica Romero-Lopez, Julien G Roth, Min Tseng, Aaron M Fullerton and Kimberly A Homan

Biofabrication, 2024, 16, 042006
DOI: 10.1088/1758-5090/ad6933

Modeling Pharmacokinetic Profiles for Assessment of Anti-Cancer Drug on a Microfluidic System

Yaqiong Guo, Pengwei Deng, Wenwen Chen and Zhongyu Li

Micromachines, 2020, 11, 551
DOI: 10.3390/mi11060551

Unraveling Caco-2 cells through functional and transcriptomic assessments

Ye Eun Jeong, Katherine Shea and Kevin A. Ford

Regulatory Toxicology and Pharmacology, 2025, 156, 105771
DOI: 10.1016/j.yrtph.2025.105771

Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development

Passley Hargrove-Grimes, Lucie A. Low and Danilo A. Tagle

Cells Tissues Organs, 2022, 211, 269
DOI: 10.1159/000517422

Human ileal organoid model recapitulates clinical incidence of diarrhea associated with small molecule drugs

David G. Belair, Richard J. Visconti, Miyoun Hong, Mathieu Marella, Matthew F. Peters, Clay W. Scott and Kyle L. Kolaja

Toxicology in Vitro, 2020, 68, 104928
DOI: 10.1016/j.tiv.2020.104928

In Vivo Observation of Lidocaine-Encapsulated Polymyxin/Glycol Nanoparticles Wound Dressing for the Treatment and Care of Abdominal Pain Incision in Intensive Care Unit

Zhenfei Pan, Jinqiang Zhu, Yi Mao, Zhenzhen Jiang, Wei Wu, Yamei Shao and Lili Chen

J Polym Environ, 2021, 29, 3732
DOI: 10.1007/s10924-021-02093-7

The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary

Thomas K. Baker, Terry R. Van Vleet, Prathap Kumar Mahalingaiah, Taraka Sai Pavan Grandhi, Raymond Evers, Jason Ekert, James R. Gosset, Silvi A. Chacko and Anna K. Kopec

Drug Metabolism and Disposition, 2024, 52, 198
DOI: 10.1124/dmd.123.001510

Shaping the future of abdominal and pelvic pain research with novel scientific and technological advances

Anna P. Malykhina

Front. Pain Res., 2026, 7
DOI: 10.3389/fpain.2026.1738762

Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip

Huub J. Weener, Heleen H. T. Middelkamp and Andries D. Van der Meer

Front. Toxicol., 2024, 6
DOI: 10.3389/ftox.2024.1513002

Organoid models: the future companions of personalized drug development

Francesco Piraino, Mariana Costa, Marine Meyer, Georgina Cornish, Camilla Ceroni, Virginie Garnier, Sylke Hoehnel-Ka and Nathalie Brandenberg

Biofabrication, 2024, 16, 032009
DOI: 10.1088/1758-5090/ad3e30

Organ‐on‐a‐chip technologies for biomedical research and drug development: A focus on the vasculature

Diosangeles Soto Veliz, Kai‐Lan Lin and Cecilia Sahlgren

Smart Medicine, 2023, 2
DOI: 10.1002/SMMD.20220030

Emerging advances in intestinal models for in vitro preclinical research

Precious Adedayo Adesina, Masato Ooka, Charlotte TeKrony and Menghang Xia

American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025, 329, G403
DOI: 10.1152/ajpgi.00087.2025

Application of new approach methodologies for nonclinical safety assessment of drug candidates

Mario Beilmann, Karissa Adkins, Harrie C. M. Boonen, Philip Hewitt, Wenyue Hu, Robert Mader, Susanne Moore, Payal Rana, Thomas Steger-Hartmann, Remi Villenave and Terry van Vleet

Nat Rev Drug Discov, 2025, 24, 705
DOI: 10.1038/s41573-025-01182-9

Microphysiological systems in early stage drug development: Perspectives on current applications and future impact

Anna K. Kopec, Ryuji Yokokawa, Nasir Khan, Ikuo Horii, James E. Finley, Christine P. Bono, Carol Donovan, Jessica Roy, Julie Harney, Andrew D. Burdick, Bart Jessen, Shuyan Lu, Mark Collinge, Ramin Banan Sadeghian, Mazin Derzi, Lindsay Tomlinson and John E. Burkhardt

J. Toxicol. Sci., 2021, 46, 99
DOI: 10.2131/jts.46.99